AKR1B10 and hepatocellular carcinoma: In preclinical models, targeted expression of AKR1B10 promotes HCC cell growth and proliferation 35, but studies on clinical samples of HCC indicated that AKR1B10 was upregulated in well differentiated and early-stage tumors and thus was proposed as a positive prognostic marker 49.